About
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Visit company website
5 years, 4 months ago
Senseonics Holdings, Inc is currently in a long term uptrend where the price is trading 71.1% above its 200 day moving average.
From a valuation standpoint, the stock is 91.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 117.4.
Senseonics Holdings, Inc's total revenue sank by 56.6% to $4M since the same quarter in the previous year.
Its net income has dropped by 185.4% to $-102M since the same quarter in the previous year.
Finally, its free cash flow grew by 76.2% to $-8M since the same quarter in the previous year.
Based on the above factors, Senseonics Holdings, Inc gets an overall score of 3/5.